By creating a new, simple nutrition label that goes on the front-of-package (FOP), the FDA believes they can make nutrition ...

The Food and Drug Administration recalled nearly 85 million units through the first half of the year and managing this ...

The US Food and Drug Administration (FDA) has approved AbbVie’s supplemental new drug application, updating the indication ...

A black box warning is the FDA’s most stringent for a prescription drug or medical device. Since 2003, it has appeared on all estrogen menopause drugs. It warns of risks such as breast and uterine ...

With the United States surging its military presence in the region and bombing boats, countries in the Caribbean are seeing ...

Afrezza is a rapid-acting inhaled human insulin that is currently approved to improve glycemic control in adults with diabetes mellitus.

Discover why Editas Medicine targets high LDL cholesterol with in-the-body gene editing. Click here to read my most recent ...

More than 1,000 women say Pfizer ignored evidence linking Depo-Provera to brain tumors—and used the FDA’s decision to protect itself.

By Krishna N. Das and Aditya Kalra NEW DELHI (Reuters) -Indian authorities have accused Balaji Amines of producing pharmaceutical-grade propylene glycol without a drug manufacturing licence, after ...

Legend Biotech ( ($LEGN) ) has issued an announcement. On October 10, 2025, Legend Biotech announced that the U.S. FDA approved a label update for ...

The FDA has approved an updated indication for upadacitinib (Rinvoq; AbbVie) in inflammatory bowel disease (IBD), allowing its use in adults with moderately to severely active ulcerative colitis or ...

The elevated lead levels were discovered during state-level product testing, and the results were then verified by the FDA, ...